Center for Innovation in Molecular and Pharmaceutical Sciences, Dr. Reddy’s Institute of Life Sciences (DRILS), University of Hyderabad Campus, Hyderabad, TG 500046, India
Soma Behera
Center for Innovation in Molecular and Pharmaceutical Sciences, Dr. Reddy’s Institute of Life Sciences (DRILS), University of Hyderabad Campus, Hyderabad, TG 500046, India
Sireesh T. Kumar
Department of Biotechnology, University of Hyderabad, Hyderabad 500046, India
Tapan Shah
Department of Biochemistry, Saurashtra University, Rajkot 360005, India
Rebecca Kristina Edwin
Center for Innovation in Molecular and Pharmaceutical Sciences, Dr. Reddy’s Institute of Life Sciences (DRILS), University of Hyderabad Campus, Hyderabad, TG 500046, India
Phanithi Prakash Babu
Department of Biotechnology, University of Hyderabad, Hyderabad 500046, India
Partha Chakrabarti
Indian Institute of Chemical Biology, Jadavpur, Kolkata 700032, India
Kishore V.L. Parsa
Center for Innovation in Molecular and Pharmaceutical Sciences, Dr. Reddy’s Institute of Life Sciences (DRILS), University of Hyderabad Campus, Hyderabad, TG 500046, India; Corresponding author
Parimal Misra
Center for Innovation in Molecular and Pharmaceutical Sciences, Dr. Reddy’s Institute of Life Sciences (DRILS), University of Hyderabad Campus, Hyderabad, TG 500046, India; Corresponding author
Summary: The physiological and metabolic functions of PIMT/TGS1, a third-generation transcriptional apparatus protein, in glucose homeostasis sustenance are unclear. Here, we observed that the expression of PIMT was upregulated in the livers of short-term fasted and obese mice. Lentiviruses expressing Tgs1-specific shRNA or cDNA were injected into wild-type mice. Gene expression, hepatic glucose output, glucose tolerance, and insulin sensitivity were evaluated in mice and primary hepatocytes. Genetic modulation of PIMT exerted a direct positive impact on the gluconeogenic gene expression program and hepatic glucose output. Molecular studies utilizing cultured cells, in vivo models, genetic manipulation, and PKA pharmacological inhibition establish that PKA regulates PIMT at post-transcriptional/translational and post-translational levels. PKA enhanced 3′UTR-mediated translation of TGS1 mRNA and phosphorylated PIMT at Ser656, increasing Ep300-mediated gluconeogenic transcriptional activity. The PKA-PIMT-Ep300 signaling module and associated PIMT regulation may serve as a key driver of gluconeogenesis, positioning PIMT as a critical hepatic glucose sensor.